Lemaitre Vascular PE ratio LMAT

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: 29.6×
10-year median: 42.0×
Against its 10-year history: 13th; percentile: 0 is its lowest day, 100 its highest
10-year range: 21.4× to 73.3×
Peer median: 38.9×

Lemaitre Vascular's PE ratio is 29.6× as of Oct 23, 2026: a share price of $84.45 against $2.85 of earnings per share over the last twelve months.

That is below its ten-year median of 42.0×, lower than on 87% of days in the last ten years.

Over that time it ranged from 21.4× in Dec 2018 to 73.3× in Jun 2023.

The median for 10 medical instruments and supplies stocks of a similar size is 38.9×.

PE ratio over time

median 42×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	29.6×	27.7×	45.7×
2025	36.1×	35.8×	54.4×
2024	50.7×	44.6×	59.0×
2023	46.9×	40.1×	73.3×
2022	47.9×	31.1×	54.2×
2021	38.1×	35.5×	55.3×
2020	43.5×	24.3×	43.5×
2019	38.1×	21.8×	39.0×
2018	22.6×	21.4×	47.6×
2017	41.4×	40.3×	56.6×
2016	46.1×	30.4×	46.1×
2015	43.1×	31.3×	48.4×
2014	44.5×	37.6×	55.9×
2013	40.5×	34.2×	49.2×
2012	45.0×	33.3×	50.0×

Against its peers

Companies in Medical - Instruments & Supplies nearest Lemaitre Vascular's size, closest first, today.

Company	PE ratio
LMATLemaitre Vascular	29.6×
INSPInspire Medical Systems	15.4×
UFPTUFP Technologies	31.9×
EYENational Vision	30.6×
CDRECadre	37.0×
BVSBioventus	19.4×
ATRCAtriCure	281×
WRBYWarby Parker	370×
STAAStaar Surgical	323×
IRMDIradimed	47.9×
NVSTEnvista	40.7×
Peer median	38.9×

Where Lemaitre Vascular ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Lemaitre Vascular

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.